Details for New Drug Application (NDA): 220142
✉ Email this page to a colleague
The generic ingredient in YUVEZZI is brimonidine tartrate; carbachol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the brimonidine tartrate; carbachol profile page.
Summary for 220142
| Tradename: | YUVEZZI |
| Applicant: | Visus |
| Ingredient: | brimonidine tartrate; carbachol |
| Patents: | 0 |
Pharmacology for NDA: 220142
| Mechanism of Action | Adrenergic alpha-Agonists Cholinergic Agonists |
Suppliers and Packaging for NDA: 220142
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| YUVEZZI | brimonidine tartrate; carbachol | SOLUTION/DROPS;OPHTHALMIC | 220142 | NDA | Visus Therapeutics, Inc. | 84892-275 | 84892-275-30 | 6 POUCH in 1 CARTON (84892-275-30) / 5 VIAL, SINGLE-DOSE in 1 POUCH (84892-275-02) / .16 mL in 1 VIAL, SINGLE-DOSE (84892-275-01) |
| YUVEZZI | brimonidine tartrate; carbachol | SOLUTION/DROPS;OPHTHALMIC | 220142 | NDA | Visus Therapeutics, Inc. | 84892-275 | 84892-275-99 | 1 POUCH in 1 CARTON (84892-275-99) / 5 VIAL, SINGLE-DOSE in 1 POUCH (84892-275-02) / .16 mL in 1 VIAL, SINGLE-DOSE (84892-275-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.1%;2.75% | ||||
| Approval Date: | Jan 28, 2026 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
